Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.

Título

Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.

Autor

Kaj Blennow, Andri Lemarquis, Tessa Campbell, Maribel Aranda-Guillén, Viktoria Hennings, Petter Brodin, Olle Kämpe, Henrik Zetterberg, Christine Wennerås, Kristina Eriksson, Nils Landegren, Yenan Bryceson, Stefan Berg, Olov Ekwall

Fecha

2021

Identificador

10.1016/j.jaci.2021.03.034

Fuente

The Journal of allergy and clinical immunology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/275c3bbec2d52253a7986fac4d4db15e.pdf

Colección

Coronavirus

Citación

Kaj Blennow, Andri Lemarquis, Tessa Campbell, Maribel Aranda-Guillén, Viktoria Hennings, Petter Brodin, Olle Kämpe, Henrik Zetterberg, Christine Wennerås, Kristina Eriksson, Nils Landegren, Yenan Bryceson, Stefan Berg, Olov Ekwall, “Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.,” SOCICT Open, consulta 17 de abril de 2026, https://www.socictopen.socict.org/items/show/9115.

Formatos de Salida

Position: 7996 (28 views)